BR112012018626A8 - novo polimorfo de cloridrato de éster de (4-hdiroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil) - Google Patents

novo polimorfo de cloridrato de éster de (4-hdiroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil)

Info

Publication number
BR112012018626A8
BR112012018626A8 BR112012018626A BR112012018626A BR112012018626A8 BR 112012018626 A8 BR112012018626 A8 BR 112012018626A8 BR 112012018626 A BR112012018626 A BR 112012018626A BR 112012018626 A BR112012018626 A BR 112012018626A BR 112012018626 A8 BR112012018626 A8 BR 112012018626A8
Authority
BR
Brazil
Prior art keywords
hydroxycarbamoyl
naphthalenyl
phenyl
carbamic acid
ester hydrochloride
Prior art date
Application number
BR112012018626A
Other languages
English (en)
Other versions
BR112012018626B1 (pt
BR112012018626A2 (pt
Inventor
Zenoni Maurizio
Turchetta Stefano
Original Assignee
Chemi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemi Spa filed Critical Chemi Spa
Publication of BR112012018626A2 publication Critical patent/BR112012018626A2/pt
Publication of BR112012018626A8 publication Critical patent/BR112012018626A8/pt
Publication of BR112012018626B1 publication Critical patent/BR112012018626B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

novo polimorfo de cloridrato de éster de (4-hidroxicarbamoil-fenil) - ácido carbâmico (6-dimetilamino metil-2-naftalenil). a se descreve uma nova forma cristalina do cloridrato de éster de (4-hidroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil). em particular, descreve-se aqui um polimorfo do cloridrato do éster do (4-hidroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil, caracterizado por um espectro de difração de raio x de pó como indicado na figura 1, e/ou por um perfil de dsc como indicado na figura 2, e/ou por um perfil de tga como indicado na figura 3 e/ou por um espectro de ir como indicado na figura 4.
BR112012018626-4A 2010-01-28 2010-12-03 Novo polimorfo de cloridrato do éster do (4-hdroxicarbamoil-fenil)-ácido carbâmico (6- dietilamino metil-2-naftalenil) BR112012018626B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A000121 2010-01-28
ITMI2010A000121A IT1397912B1 (it) 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
PCT/IB2010/055560 WO2011092556A1 (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester

Publications (3)

Publication Number Publication Date
BR112012018626A2 BR112012018626A2 (pt) 2016-05-03
BR112012018626A8 true BR112012018626A8 (pt) 2017-12-19
BR112012018626B1 BR112012018626B1 (pt) 2021-06-08

Family

ID=42288805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012018626-4A BR112012018626B1 (pt) 2010-01-28 2010-12-03 Novo polimorfo de cloridrato do éster do (4-hdroxicarbamoil-fenil)-ácido carbâmico (6- dietilamino metil-2-naftalenil)

Country Status (20)

Country Link
US (1) US8518988B2 (pt)
EP (1) EP2528599B1 (pt)
JP (1) JP2013518091A (pt)
KR (1) KR101723532B1 (pt)
CN (1) CN102665712B (pt)
AU (1) AU2010344330B2 (pt)
BR (1) BR112012018626B1 (pt)
CA (1) CA2780432C (pt)
CY (1) CY1115409T1 (pt)
DK (1) DK2528599T3 (pt)
ES (1) ES2489467T3 (pt)
HK (1) HK1175699A1 (pt)
HR (1) HRP20140610T1 (pt)
IT (1) IT1397912B1 (pt)
MX (1) MX2012008777A (pt)
PL (1) PL2528599T4 (pt)
PT (1) PT2528599E (pt)
RU (1) RU2552354C2 (pt)
SI (1) SI2528599T1 (pt)
WO (1) WO2011092556A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX349767B (es) * 2012-02-03 2017-08-11 Italfarmaco Spa Cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi-metil) -naftalen-2-il-metil]-amonio para su uso en el tratamiento de distrofia muscular.
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
IT201900003281A1 (it) * 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3574185B2 (ja) * 1994-09-02 2004-10-06 小松屋化学株式会社 無水クエン酸トリマグネシウムおよびその製法
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
WO1997046526A1 (en) * 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
JP2008538581A (ja) * 2005-04-22 2008-10-30 ワイス {[(2r)−7−(2,6−ジクロロフェニル)−5−フルオロ−2,3−ジヒドロ−1−ベンゾフラン−2−イル]メチル}アミン塩酸塩の結晶形態
EP1805148A2 (en) * 2005-08-16 2007-07-11 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
EP2185559A1 (en) * 2007-08-03 2010-05-19 Boehringer Ingelheim International GmbH Crystalline form of a dihydropteridione derivative

Also Published As

Publication number Publication date
CN102665712B (zh) 2013-10-16
EP2528599B1 (en) 2014-05-21
RU2012134703A (ru) 2014-03-10
BR112012018626B1 (pt) 2021-06-08
SI2528599T1 (sl) 2014-09-30
HK1175699A1 (pt) 2013-07-12
KR20120123259A (ko) 2012-11-08
JP2013518091A (ja) 2013-05-20
PT2528599E (pt) 2014-07-18
CN102665712A (zh) 2012-09-12
ITMI20100121A1 (it) 2011-07-29
EP2528599A1 (en) 2012-12-05
IT1397912B1 (it) 2013-02-04
PL2528599T4 (pl) 2014-11-28
MX2012008777A (es) 2012-09-07
CA2780432C (en) 2017-02-21
PL2528599T3 (pl) 2014-10-31
AU2010344330B2 (en) 2014-11-13
KR101723532B1 (ko) 2017-04-06
BR112012018626A2 (pt) 2016-05-03
DK2528599T3 (da) 2014-06-30
CY1115409T1 (el) 2017-01-04
ES2489467T3 (es) 2014-09-02
WO2011092556A1 (en) 2011-08-04
US20120302633A1 (en) 2012-11-29
RU2552354C2 (ru) 2015-06-10
US8518988B2 (en) 2013-08-27
HRP20140610T1 (hr) 2014-08-15
AU2010344330A1 (en) 2012-05-24
CA2780432A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
ZA201401482B (en) Use of acylsulfonamides for improving plant yield
EP2593983B8 (en) Anode material, metal secondary battery, and method for production of anode material
HK1184492A1 (zh) 體細胞至誘導的重編程神經幹細胞 的轉化
PL2690952T3 (pl) Kompozycja regulująca wzrost roślin
MY158648A (en) Compositions for modulating a kinase cascade and methods of use thereof
SG11202109034VA (en) Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock
HUE035861T2 (hu) Egy pleuromutilin kristályos formája
MX2013005069A (es) Formas cristalinas de sal de clorhidrato de (4a-r, 9a-s)-1-(1h-benzoimidazol-5-carbonil)-2,3,4,4a,9,9a,-hexahidro-1h -indeno[2,1-b]piridin-6-carbonitrilo y su uso como inhibidores de 11 beta-hidroxiesteroide deshidrogenasa 1.
EP2791317A4 (en) NEW METHOD OF BACTERIA BREEDING TO INCREASE THE CAPACITY OF CAPSULAR POLYESES
LT2525641T (lt) Augalų sėklų daigumo savybių įvertinimo būdas
EP2463266A4 (en) PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
IN2012DN01342A (pt)
EP2465293A4 (en) TRANSFER METHOD FOR MINIMIZING DATA TREATED TO A TARGET NODE
BR112014009775A2 (pt) composição, método, semente e composto de fórmula 1
BR112012018626A8 (pt) novo polimorfo de cloridrato de éster de (4-hdiroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil)
MX2011013057A (es) Metodo para producir derivado de benzotioamida 4-sustituida.
MX2014003883A (es) Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y transtornos relacionados.
EP2192189A4 (en) PROCESS FOR THE PRODUCTION OF STARCHIC ACID
EP2527297A4 (en) METHOD FOR THE PRODUCTION OF ZINC TOLUENESULFONATE, ZINC TOLUENESULFONATE AND METHOD FOR THE PRODUCTION OF CARBAMATE
SG11201504058SA (en) Highly Efficient Production Of Lactic Acid From Hemicellulose Sugars By Newly Isolated Thermophilic Bacillus Coagulans Strains
WO2010146595A3 (en) Novel polymorphs of flibanserin hydrochloride
ZA201402773B (en) Use of phenylpyrazolin-3-carboxylates for improving plant yield
ZA201304704B (en) Indirect substrates for microorganisms metabolizing 1,2-propanediol
PL2658987T3 (pl) Fermentacyjne wytwarzanie hydroksyanalogu metioniny

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/12/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF